EU-JAMRAI is a European Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI) that was active from 2018 through 2021. It brought together 44 partners and more than 40 stakeholders, including the Global AMR R&D Hub. The mission was to foster synergies among EU Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI.
To ensure that project results remain available, alongside other stakeholders the Global AMR R&D Hub has agreed to host the following documents that are relevant to its remit:
- Gathering of national research priorities from France, Greece, the Netherlands, Norway, Slovenia, Spain and the United Kingdom and gap identification
- Publication on infection prevention and control research priorities
- An overview of the mapping of national AMR action plans from 12 countries
- Publication on Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe
